PT1358182E - Derivados de diazocinas e sua utilizacao como inibidores de triptase - Google Patents
Derivados de diazocinas e sua utilizacao como inibidores de triptaseInfo
- Publication number
- PT1358182E PT1358182E PT02704674T PT02704674T PT1358182E PT 1358182 E PT1358182 E PT 1358182E PT 02704674 T PT02704674 T PT 02704674T PT 02704674 T PT02704674 T PT 02704674T PT 1358182 E PT1358182 E PT 1358182E
- Authority
- PT
- Portugal
- Prior art keywords
- inhibitors
- diazocines
- triptase
- derivatives
- tryp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01102098 | 2001-01-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1358182E true PT1358182E (pt) | 2004-12-31 |
Family
ID=8176347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02704674T PT1358182E (pt) | 2001-01-31 | 2002-01-26 | Derivados de diazocinas e sua utilizacao como inibidores de triptase |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6924305B2 (pt) |
| EP (1) | EP1358182B1 (pt) |
| JP (1) | JP2004517943A (pt) |
| AT (1) | ATE273302T1 (pt) |
| AU (1) | AU2002238522B8 (pt) |
| CA (1) | CA2438594A1 (pt) |
| DE (1) | DE60200935T2 (pt) |
| DK (1) | DK1358182T3 (pt) |
| ES (1) | ES2225758T3 (pt) |
| PT (1) | PT1358182E (pt) |
| SI (1) | SI1358182T1 (pt) |
| WO (1) | WO2002060895A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE348803T1 (de) | 2001-06-19 | 2007-01-15 | Altana Pharma Ag | Tryptase-inhibitoren |
| WO2006044133A1 (en) * | 2004-09-24 | 2006-04-27 | Axys Pharmaceuticals, Inc. | Active ketone inhibitors of tryptase |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10501238A (ja) | 1994-06-01 | 1998-02-03 | アリス ファーマシューティカル コーポレイション | 肥満細胞媒介症状を治療するための組成物及び方法 |
| EP0782571A1 (en) | 1994-09-23 | 1997-07-09 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell inflammatory condition |
| KR20000029679A (ko) * | 1996-07-30 | 2000-05-25 | 헤이즈 더블유.그쉬웬드 다니엘 에이치.페트리 | 트립타아제활성관련질병을치료하기위한화합물및조성물 |
| AU8997498A (en) | 1997-09-05 | 1999-03-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
| AU1208999A (en) | 1997-11-10 | 1999-05-31 | Array Biopharma, Inc. | Compounds which inhibit tryptase activity |
| US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| JP2002502850A (ja) | 1998-02-06 | 2002-01-29 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | トリプターゼ阻害物質 |
| AU2723099A (en) | 1998-02-06 | 1999-08-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
| WO2000014097A2 (de) | 1998-09-04 | 2000-03-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue pyranosen |
| US6673786B1 (en) | 1999-08-10 | 2004-01-06 | Altana Pharma Ag | Tryptase inhibitors |
| DE19937721A1 (de) | 1999-08-10 | 2001-02-15 | Max Planck Gesellschaft | Neue Diketopiperazine |
| JP2003509417A (ja) | 1999-09-14 | 2003-03-11 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
| TR200402164T4 (tr) | 1999-12-20 | 2004-10-21 | Altana Pharma Ag | Triptaz inhibitörler |
| US7015325B2 (en) | 1999-12-20 | 2006-03-21 | Altana Pharma Ag | Tryptase inhibitors |
-
2002
- 2002-01-26 CA CA002438594A patent/CA2438594A1/en not_active Abandoned
- 2002-01-26 DE DE60200935T patent/DE60200935T2/de not_active Expired - Fee Related
- 2002-01-26 DK DK02704674T patent/DK1358182T3/da active
- 2002-01-26 WO PCT/EP2002/000831 patent/WO2002060895A1/en active IP Right Grant
- 2002-01-26 AT AT02704674T patent/ATE273302T1/de not_active IP Right Cessation
- 2002-01-26 EP EP02704674A patent/EP1358182B1/en not_active Expired - Lifetime
- 2002-01-26 SI SI200230037T patent/SI1358182T1/xx unknown
- 2002-01-26 US US10/466,906 patent/US6924305B2/en not_active Expired - Fee Related
- 2002-01-26 ES ES02704674T patent/ES2225758T3/es not_active Expired - Lifetime
- 2002-01-26 AU AU2002238522A patent/AU2002238522B8/en not_active Ceased
- 2002-01-26 PT PT02704674T patent/PT1358182E/pt unknown
- 2002-01-26 JP JP2002561044A patent/JP2004517943A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ES2225758T3 (es) | 2005-03-16 |
| AU2002238522A1 (en) | 2002-08-12 |
| ATE273302T1 (de) | 2004-08-15 |
| EP1358182A1 (en) | 2003-11-05 |
| US20040072762A1 (en) | 2004-04-15 |
| WO2002060895A1 (en) | 2002-08-08 |
| EP1358182B1 (en) | 2004-08-11 |
| AU2002238522B2 (en) | 2006-12-21 |
| US6924305B2 (en) | 2005-08-02 |
| SI1358182T1 (en) | 2005-02-28 |
| DE60200935T2 (de) | 2005-09-01 |
| JP2004517943A (ja) | 2004-06-17 |
| DE60200935D1 (de) | 2004-09-16 |
| AU2002238522B8 (en) | 2007-01-18 |
| CA2438594A1 (en) | 2002-08-08 |
| DK1358182T3 (da) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0608886B8 (pt) | derivados de n-sulfonilpirróis e seus usos | |
| BR0313330A (pt) | Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4 | |
| ATE348616T1 (de) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
| ATE353217T1 (de) | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren | |
| HRP20050228A2 (en) | Novel phenanthridines | |
| ATE461217T1 (de) | Glp-1-verbindungen | |
| EA200601587A1 (ru) | Новые амидозамещённые гидрокси-6-фенилфенантридины | |
| NO20051082L (no) | Antimikrobielle kinoloner, deres sammensetninger og anvendelser | |
| TW200600499A (en) | Novel amido-substituted hydroxy-6-phenylphenanthridines | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| BR0313385A (pt) | Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz | |
| PT1086096E (pt) | Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4 | |
| SE0301650D0 (sv) | Novel compounds | |
| DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
| ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| SE9903290D0 (sv) | Novel compounds | |
| DK1558580T3 (da) | N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner | |
| EA200301101A1 (ru) | Производные пиперазина и их применение в качестве ингибиторов pde4 | |
| ATE269313T1 (de) | Tryptase-inhibitoren | |
| PT1244614E (pt) | Inibidores de triptase | |
| NO20053562L (no) | Nye aminobenzofenonforbindelser | |
| PT1358182E (pt) | Derivados de diazocinas e sua utilizacao como inibidores de triptase | |
| PT1208089E (pt) | Derivados de diazocin-diona e sua utilizacao como inibidores de triptase | |
| ATE348803T1 (de) | Tryptase-inhibitoren | |
| ATE321760T1 (de) | N-aryl-2-oxazolidinone und deren derivate |